NIH clinical trial will test precision medicine treatments for myeloid cancers

🔗 Access full article via NCI News Releases

NCI has launched myeloMATCH, a precision medicine treatment trial that will test treatment combinations targeting specific genetic changes in people with acute myeloid leukemia and myelodysplastic syndromes.